19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers

Clinical trial NCT04464200 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04464200
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma Primary Mediastinal Large B Cell Lymphoma Transformed Follicular Lymphoma to Diffuse Large B Cell Lymphoma Chronic Lymphocytic Leukemia Indolent Non-Hodgkin Lymphoma Marginal Zone Lymphoma Waldenstrom Macroglobulinemia Burkitt's Lymphoma Primary CNS Lymphoma

Start date: 2020-07-06
Primary completion: 2026-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.